WASHINGTON, D.C. – U.S. Department of Health and Human Services (HHS) announced their decision Wednesday to rescind all guidance related to U.S. Food and Drug Administration (FDA) oversight of laboratory developed tests (LDTs), a move that could have broad, negative health consequences.
A statement from Gary M. Reedy, CEO of the American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN) on the death of civil rights champion and U.S. Congressman Rep. John Lewis from pancreatic cancer.
The American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), support efforts to make nutrition research a federal priority.
Washington, D.C.—Today the House Appropriations Committee will vote on a proposed FY 2021 spending bill that includes a $5.5 billion funding increase for the National Institutes of Health (NIH)—half of which is emergency funding and the remainder of which will be divided among the various institu
Washington, D.C.—Today the House Labor Health and Human Services Appropriations Subcommittee on Health will vote on a FY 2021 spending bill that includes a $5.5 billion funding increase for the National Institutes of Health (NIH)—half of which is emergency funding and the remainder of which will
Setting a dangerous precedent that puts kids and public health at risk, today the U.S. Food and Drug Administration authorized the marketing of Philip Morris’ IQOS heated cigarette as a “modified risk tobacco product” despite the FDA’s acknowledgement that Philip Morris failed to show that IQOS presents a reduced risk of tobacco-related disease...
Oklahomans approval of Medicaid expansion will improve health outcomes and reduce cancer disparities for 200,000 citizens now eligible for health care coverage.
Today the U.S. House of Representatives is expected to vote on a legislative package containing provisions aimed at improving access to affordable health care, including for those with serious pre-existing conditions like cancer.
The American Cancer Society Cancer Action Network (ACS CAN) submitted testimony today to the House Energy and Commerce Committee on the topic of racial and ethnic disparities in the health care system that often result in an unequal cancer burden. The hearing is focused on disparities in the overall health care system, as well as those around COVID-19.
Today 29 patient and consumer groups representing millions of people nationwide with pre-existing health conditions issued the following statement in response to administration’s final rule. The rule, finalized Friday, attempts to undermine Section 1557 of the Affordable Care Act by removing explicit protections against discrimination of patients by providers and institutions.